CoChat

Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) selectively induces apoptosis in transformed cells. Normal cells and certain tumor cells can evade Apo2L/TRAIL induced cell death, but the determinants of Apo2L/TRAIL sensitivity are poorly understood. To better understand the factors that contribute to Apo2L/TRAIL resistance, we characterized two colon carcinoma lines with pronounced differences in Apo2L/TRAIL sensitivity. Colo205 cells are highly sensitive to Apo2L/TRAIL whereas Colo320 cells are unresponsive. Components of the DISC (death inducing signaling complex) could be immunoprecipitated from both cell lines in response to Apo2L/TRAIL. Sensitizing agents including a proteasome inhibitor conferred Apo2L/TRAIL sensitivity in Colo320 cells, indicating that the apoptotic machinery was intact and functional. We specifically suppressed the expression of Bcl-2, FLIP or XIAP in Colo320 cells. Downregulation of either FLIP or XIAP but not Bcl-2 restored sensitivity of Colo320 cells to Apo2L/TRAIL. Moreover, stable knockdown of XIAP expression in Colo320 subcutaneous tumors resulted in suppression of tumor growth and sensitivity to Apo2L/TRAIL in vivo. Our results indicate that only a specific subset of anti-apoptotic proteins can confer resistance to Apo2L/TRAIL in Colo320 cells. Elucidation of the factors that contribute to Apo2L/TRAIL resistance in tumor cells may provide insight into combination therapies with Apo2L/TRAIL in a clinical setting.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10495-007-0076-6

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. Walczak H, Miller RE, Ariail K et al (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. [see comment]. Nat Med 5:157–163 · DOI · Paper page

Cited by

See all 42

Metadata

Authors
Lippa, M. S., Strockbine, L. D., Le, T. T., Branstetter, D. G., Strathdee, C. A., & Holland, P. M.
Affiliations
Amgen (United States) (US)
Corresponding author
Holland, Pamela M.
Venue
Apoptosis
Published
2007-04-18
Volume
12
Issue
8
Pages
1465-1478
ISSN
  • 1360-8185 (ISSN-L)
  • 1573-675X
OpenAlex
W2033871520
Cited by
42
References
57
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2014: 3 · 2013: 2 · 2012: 4
FWCI
1.86
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • APOPTOSIS (publishedVersion)
  • PubMed (publishedVersion)
Funders
Amgen
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
Apo2L/TRAIL, TRAIL resistance, colon cancer, anti-apoptotic proteins, XIAP, c-FLIP, Bcl-2, death-inducing signaling complex, tumor growth inhibition, combination therapy
MeSH terms
Animals, Carcinoma, Colonic Neoplasms, Female, Humans, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Mice, SCID, Apoptosis, Drug Resistance, Neoplasm, Xenograft Model Antitumor Assays, Apoptosis Regulatory Proteins, Mice, X-Linked Inhibitor of Apoptosis Protein, Receptors, Death Domain, TNF-Related Apoptosis-Inducing Ligand, Death Domain Receptor Signaling Adaptor Proteins, CASP8 and FADD-Like Apoptosis Regulating Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. https://app.cochat.ai/papers/10.1007/s10495-007-0076-6
The paper
Lippa, M. S., Strockbine, L. D., Le, T. T., Branstetter, D. G., Strathdee, C. A., & Holland, P. M. (2007). Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Apoptosis. https://doi.org/10.1007/s10495-007-0076-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.